Treatment of COPD groups GOLD A and B with inhaled corticosteroids in the COSYCONET cohort: determinants and consequences

GOLD A and B COPD patients are often treated with inhaled corticosteroids (ICS), which may benefit only a subgroup of these patients. Click to read more.

Saved in:
Bibliographic Details
Main Authors: Lutter, Johanna I. (Author) , Jörres, Rudolf A. (Author) , Trudzinski, Franziska (Author) , Alter, Peter (Author) , Kellerer, Christina (Author) , Watz, Henrik (Author) , Welte, Tobias (Author) , Bals, Robert (Author) , Kauffmann-Guerrero, Diego (Author) , Behr, Jürgen (Author) , Holle, Rolf (Author) , Vogelmeier, Claus F. (Author) , Kahnert, Kathrin (Author)
Format: Article (Journal)
Language:English
Published: 14 April 2021
In: The International journal of chronic obstructive pulmonary disease
Year: 2021, Volume: 16, Pages: 987-998
ISSN:1178-2005
DOI:10.2147/COPD.S304532
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2147/COPD.S304532
Verlag, lizenzpflichtig, Volltext: https://www.dovepress.com/treatment-of-copd-groups-gold-a-and-b-with-inhaled-corticosteroids-in--peer-reviewed-fulltext-article-COPD
Get full text
Author Notes:Johanna I. Lutter, Rudolf A. Jörres, Franziska C. Trudzinski, Peter Alter, Christina Kellerer, Henrik Watz, Tobias Welte, Robert Bals, Diego Kauffmann-Guerrero, Jürgen Behr, Rolf Holle, Claus F. Vogelmeier, Kathrin Kahnert, on behalf of the COSYCONET study group
Description
Summary:GOLD A and B COPD patients are often treated with inhaled corticosteroids (ICS), which may benefit only a subgroup of these patients. Click to read more.
Item Description:Gesehen am 18.05.2021
Physical Description:Online Resource
ISSN:1178-2005
DOI:10.2147/COPD.S304532